ProCE Banner Activity

Optimizing Nonfactor Therapy for Hemophilia A

Slideset Download
Download this slideset to learn more about the latest evidence on personalizing nonfactor therapy to optimize outcomes for patients with hemophilia A.

Released: December 10, 2021

Begin Activity

Share

Faculty

Guy A. Young

Guy A. Young, MD

Professor of Pediatrics
Director,
Hemostasis and Thrombosis Center
Childrens Hospital Los Angeles
University of Southern California Keck School of Medicine
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Sanofi Genzyme

Takeda Pharma USA Inc Takeda Onc Co

Faculty Disclosure

Primary Author

Guy A. Young, MD

Professor of Pediatrics
Director,
Hemostasis and Thrombosis Center
Childrens Hospital Los Angeles
University of Southern California Keck School of Medicine
Los Angeles, California

Guy A. Young, MD, has disclosed that he has received funds for research support from Genentech/Roche; fees for non-CME/CE services from Bioverativ, Genentech/Roche, and Sanofi; and consulting fees from CSL-Behring, Genentech/Roche, Grifols, Hema Biologics, Kedrion, Novo Nordisk, Sanofi, Spark, and Takeda.